Correlation Between Viridian Therapeutics and Omnicom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Omnicom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Omnicom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Omnicom Group, you can compare the effects of market volatilities on Viridian Therapeutics and Omnicom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Omnicom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Omnicom.

Diversification Opportunities for Viridian Therapeutics and Omnicom

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Viridian and Omnicom is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Omnicom Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omnicom Group and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Omnicom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omnicom Group has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Omnicom go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Omnicom

Assuming the 90 days trading horizon Viridian Therapeutics is expected to under-perform the Omnicom. In addition to that, Viridian Therapeutics is 1.96 times more volatile than Omnicom Group. It trades about -0.02 of its total potential returns per unit of risk. Omnicom Group is currently generating about 0.08 per unit of volatility. If you would invest  10,170  in Omnicom Group on August 30, 2024 and sell it today you would earn a total of  303.00  from holding Omnicom Group or generate 2.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Viridian Therapeutics  vs.  Omnicom Group

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Viridian Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Omnicom Group 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Omnicom Group are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Omnicom is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Viridian Therapeutics and Omnicom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Omnicom

The main advantage of trading using opposite Viridian Therapeutics and Omnicom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Omnicom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omnicom will offset losses from the drop in Omnicom's long position.
The idea behind Viridian Therapeutics and Omnicom Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities